{"DataElement":{"publicId":"4383271","version":"1","preferredName":"PI-RADS Overall Classification Score","preferredDefinition":"Score to represent a generalization for a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS).","longName":"PIRADS_OVRALL_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4383082","version":"1","preferredName":"PI-RADS Overall Classification","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._Including everything._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"4382371v1.0:4383080v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4382371","version":"1","preferredName":"Prostate Imaging-Reporting and Data System","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","longName":"C116385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93A8-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4383080","version":"1","preferredName":"Overall Classification","preferredDefinition":"Including everything.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C25605:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9CC1-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"ONEDATA","dateModified":"2014-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9CD2-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"7/9/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4382619","version":"1","preferredName":"PI-RADS Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"PIRADS_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"5","valueDescription":"Highly suspicious of malignancy","ValueMeaning":{"publicId":"4382620","version":"1","preferredName":"Highly suspicious of malignancy","longName":"4382620","preferredDefinition":"Highly suspicious of malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2A31-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2A4A-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Probably malignant","ValueMeaning":{"publicId":"4382621","version":"1","preferredName":"Probably malignant","longName":"4382621","preferredDefinition":"Probably malignant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2A54-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2A6D-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2577194","version":"1","preferredName":"Indeterminate","longName":"2577194","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2A77-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Probably benign","ValueMeaning":{"publicId":"3282209","version":"1","preferredName":"Probably benign","longName":"3282209","preferredDefinition":"Having a good chance of being the case or of coming about.: (beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Likely","conceptCode":"C85550","definition":"Having a good chance of being the case or of coming about.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD5A0967-E43F-2CC3-E040-BB89AD436ED5","latestVersionIndicator":"Yes","beginDate":"2011-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2A8B-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"1","valueDescription":"Most probably benign","ValueMeaning":{"publicId":"4382622","version":"1","preferredName":"Most probably benign","longName":"4382622","preferredDefinition":"Most probably benign","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2A96-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2AAF-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4382612","version":"1","preferredName":"Prostate Imaging-Reporting and Data System Peak Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.:The most extreme possible amount or value; the highest point.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C116385:C48054:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peak","conceptCode":"C48054","definition":"The most extreme possible amount or value; the highest point.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2947-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2A1C-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"7/8/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Overall PI-RADS classificatio","type":"Preferred Question Text","description":"Overall PI-RADS classification (Score)","url":null,"context":"CCR"},{"name":"Short Text","type":"Alternate Question Text","description":"PI-RADS Overall Score","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCB8337-E7AF-FCE5-E040-BB89AD4337D3","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}